Integra LifeSciences (IART)

• Market cap: $978M
• 1 day: -4.40%
• 5 days: -4.98%
• 1 month: -1.87%
• 3 months: -25.90%
• 6 months: -43.52%
• Year to date: -45.31%
• 1 year: -58.87%
• 5 years: -72.83%
• 10 years: -60.20%
• Sector: Healthcare
• Industry: Medical Devices

About: Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.

Employees: 4,396

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

611% more call options, than puts

Call options by funds: $512K | Put options by funds: $72K

5.31% more ownership

Funds ownership: 89.82% [Q4 2024] → 95.14% (+5.31%) [Q1 2025]

3% more capital invested

Capital invested by funds: $1.57B [Q4 2024] → $1.62B (+$43.9M) [Q1 2025]

0% more funds holding in top 10

Funds holding in top 10: 1 [Q4 2024] → 1 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 30

4% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 76

1% less funds holding

Funds holding: 220 [Q4 2024] → 217 (-3) [Q1 2025]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $12 5% downside
• Avg. target: $16.67 32% upside
• High target: $25 99% upside

3 analyst ratings

• positive: 1 33%
• neutral: 1 33%
• negative: 1 33%

JMP Securities David Turkaly	99% upside $25	Market Outperform Maintained	9 May 2025
JP Morgan Robbie Marcus	5% downside $12	Underweight Maintained	6 May 2025
Wells Fargo Vik Chopra	3% upside $13	Equal-Weight Maintained	6 May 2025